Try our Advanced Search for more refined results
Arbutus Biopharma Corp.
-
Answer | Filed: May 15, 2024 | Entered: May 15, 2024 Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Patent | Delaware
Answer to Amended Complaint Counterclaim
[SEALED] ANSWER to Amended Complaint, re: 301 Amended Complaint, with Jury Demand , COUNTERCLAIM against Arbutus Biopharma Corporation, Genevant Sciences GmbH by Moderna, Inc., ModernaTX, Inc..(Egan, Brian)
-
Motion | Filed: May 15, 2024 | Entered: May 15, 2024 Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Patent | Delaware
Miscellaneous Relief
[SEALED] MOTION and [Proposed] Order to Seal Portions of Moderna's Answer to the Amended Complaint - filed by Moderna, Inc., ModernaTX, Inc.. (Attachments: # 1 Exhibit A - proposed redactions, # 2 Exhibit B - REDACTED Answer to Amended Complaint and Counterclaims)(Egan, Brian)
-
Order | Filed: May 15, 2024 | Entered: May 15, 2024 Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Patent | Delaware
Order ~Util - Set Hearings
ORDER: A Discovery Hearing in the above-captioned matter is scheduled for Thursday, June 13, 2024 at 2:00 p.m. in Courtroom 17A, U.S. Courthouse, 601 Market Street, Philadelphia, Pa. Signed by Judge Mitchell S. Goldberg on 05/15/2024. (vfm)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login